@article{0de0f51fa3c94a67a13f02a1992b5c9f,
title = "A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia",
keywords = "CD22, acute lymphoblastic leukaemia, immunotoxin, moxetumomab pasudotox, relapsed/refractory",
author = "Short, {Nicholas J.} and Hagop Kantarjian and Elias Jabbour and Cortes, {Jorge E.} and Thomas, {Deborah A.} and Rytting, {Michael E.} and Naval Daver and Yesid Alvarado and Marina Konopleva and Partow Kebriaei and Wierda, {William G.} and DiNardo, {Courtney D.} and Carol Bivins and Deborah McCue and Richie, {Mary A.} and Farhad Ravandi",
note = "Funding Information: Supported by Medimmune and the MD Anderson Cancer Center Support Grant CA016672.",
year = "2018",
month = aug,
doi = "10.1111/bjh.14806",
language = "English (US)",
volume = "182",
pages = "442--444",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",
}